Back to results
US 2001/0034445 A1Published application
Vitronectin receptor antagonists
AssigneeSmithKline Beecham Corporation
InventorsFadia E. Ali, William E. Bondinell, Richard M. Keenan, Thomas Wen-Fu Ku, William H. Miller, James Samanen
Life of this patent
Estimating the term…
Abstract
Compounds of formula (I) are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. 1
Claims17
A compound according to formula (I):
- 58
- wherein
- A is a fibrinogen antagonist template;
- W is a linking moiety of the form —(CHRg)a—U—(CHRg)b—V—;
- Q1, Q2 and Q3 are independently N or C—Ry, provided that no more than one of Q1, Q2 and Q3 is N;
- R′ is is H or C1-6alkyl, C3-7cycloalkyl-C0-6alkyl or Ar—C0-6alkyl
- R″ is R′, —C(O)R′ or —C(O)OR′;
- Rg is H or C1-6alkyl, Het-C0-6alkyl, C3-7cycloalkyl-C0-6alkyl or Ar—C0-6alkyl;
- Rk is Rg, —C(O)Rg or —C(O)ORg
- Ri is H, C1-6alkyl, Het-C0-6alkyl, C3-7cycloalkyl-C0-6alkyl, Ar—C0-6alkyl, Het-C0-6alkyl-U′-C1-6alkyl, C3-7cycloalkyl-C0-6alkyl-U′-C1-6alkyl or Ar—C0-6alkyl-U′-C1-6alkyl;
- Ry is H, halo, —ORg, —SRg, —CN, —NRgRk, —NO2, —CF3, CF3S(O)r—, —CO2Rg, —CORg or —CONRg2;
- U and V are absent or CO, CRg2, C(═CRg2), S(O)c, O, NRg, CRgORg, CRg(ORk)CRg2, CRg2CRg(ORk), C(O)CRg2, CRg2C(O), CONRi, NRiCO, OC(O), C(O)O, C(S)O, OC(S), C(S)NRg, NRgC(S), S(O)2NRg, NRgS(O)2 N═N, NRgNRg, NRgCRg2, NRgCRg2, CRg2O, OCRg2, CRg═CRg, C≡C, Ar or Het;
- a is 0, 1 or 2;
- b is 0, 1 or 2;
- c is 0, 1 or 2;
- r is 0, 1 or 2;
- u is 0 or 1;
- and
- v is 0 or ;
- or pharmaceutically acceptable salts thereof;
- provided that:
- (i) when v is 0, and R′, R″ and Ry are H, and Q1-Q3 are CH, W-A is not 7-aminocarbonyl-2,3,4,5-tetrahydro-3-oxo-4-methyl-1H-1,4-benzodiazepine-2-acetic acid, 7-aminocarbonyl-1-acetyl-2,3,4,5-tetrahydro-3-oxo-4-methyl-1H-1,4-benzodiazepine-2-acetic acid, or 7-aminocarbonyl-2,3,4,5-tetrahydro-3-oxo-4-methyl-1H-1-benzazepine-2-acetic acid, or the methyl esters thereof;
- (ii) when v is 0 or 1 and R′, R″ and Ry are H, and Q1-Q3 are CH, W-A is not 3-propanoyl-glycyl-aspartyl-phenylalanine, or
- 59
- and the benzyl esters thereof.
22 more elements
A compound according to formula (I) in which A is chosen from the group of
- 60
- and which has 13-14 covalent bonds between the acidic moiety and the first nitrogen in the pyridine ring.
Dependencies are inferred from the claim text.